nature.com

Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children - Bone Marrow Transplantation

  • ️Okamura, J
  • ️Mon Nov 19 2007

  • Armitage JO . Bone marrow transplantation. N Engl J Med 1994; 330: 827–838.

    Article  CAS  PubMed  Google Scholar 

  • Vogelsang GB . How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196–1201.

    Article  CAS  PubMed  Google Scholar 

  • Lee SJ, Vogelsang G, Flowers MED . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215–233.

    Article  CAS  PubMed  Google Scholar 

  • Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991; 77: 1821–1828.

    CAS  PubMed  Google Scholar 

  • Arai S, Margolis J, Zaburak M, Anders V, Vogelsang GB . Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment. Biol Blood Marrow Transplant 2002; 8: 155–160.

    Article  PubMed  Google Scholar 

  • Grim J, Chladek J, Martinkova J . Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic disease. Clin Pharmacokinet 2003; 42: 139–151.

    Article  CAS  PubMed  Google Scholar 

  • Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR . Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 110: 353–356.

    Article  CAS  PubMed  Google Scholar 

  • Mack DR, Young R, Kaufman SS, Ramey L, Vanderhoof JA . Methotrexate in patients with Crohn's disease after 6-mercaptopurine. J Pediatr 1998; 132: 830–835.

    Article  CAS  PubMed  Google Scholar 

  • Boehm IB, Boehm GA, Bauer R . Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanism. Rheumatol Int 1998; 18: 59–62.

    Article  CAS  PubMed  Google Scholar 

  • van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB . Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved toxicity. Semin Arthritis Rheum 1998; 27: 277–292.

    Article  CAS  PubMed  Google Scholar 

  • Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long DG et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 1993; 329: 1225–1230.

    Article  CAS  PubMed  Google Scholar 

  • Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729–735.

    Article  CAS  PubMed  Google Scholar 

  • Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062–2068.

    CAS  PubMed  Google Scholar 

  • Przepiorka D, Ippoliti C, Khouri I, Woo M, Mehra R, Bherz DL et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. Blood 1996; 88: 4383–4389.

    CAS  PubMed  Google Scholar 

  • Giaccone L, Martin P, Carpenter P, Moravec C, Hooper H, Funke VAM et al. Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease. Bone Marrow Transplant 2005; 36: 337–341.

    Article  CAS  PubMed  Google Scholar 

  • Huang XJ, Jiang Q, Chen H, Xu L, Liu D, Chen Y et al. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 36: 343–348.

    Article  CAS  PubMed  Google Scholar 

  • Seitz M . Molecular and cellular effects of methotrexate. Curr Opin Rheumatol 1999; 11: 226–232.

    Article  CAS  PubMed  Google Scholar 

  • Imamura M, Hashino S, Kobayashi H, Kubayashi S, Hirano S, Minagawa T et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-γ, and tumor necrosis factor-α in graft-versus-host disease. Bone Marrow Transplant 1994; 13: 745–751.

    CAS  PubMed  Google Scholar 

  • Jacobsohn DA, Vogelsang GB . Anti-cytokine therapy for the treatment of graft-versus-host disease. Curr Pharm Des 2004; 10: 1195–1205.

    Article  CAS  PubMed  Google Scholar 

  • Ferrara JLM . Paradigm shift for graft-versus-host disease. Bone Marrow Transplant 1994; 14: 183–184.

    CAS  PubMed  Google Scholar 

  • Ferrara JLM, Reddy P . Pathophysiology of graft-versus-host disease. Semin Hematol 2006; 43: 3–10.

    Article  CAS  PubMed  Google Scholar 

  • Przepiorka D, Weisdorf D, Martin P, Klingemann H-G, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  • Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host disease syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.

    Article  CAS  PubMed  Google Scholar 

  • Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N et al. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood 1990; 75: 1024–1030.

    CAS  PubMed  Google Scholar 

  • Roy J, McGlave PB, Filipovich AH, Miller WJ, Blazar BR, Ramsay NK et al. Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. Bone Marrow Transplant 1992; 10: 77–82.

    CAS  PubMed  Google Scholar 

  • Khoury H, kashyap A, Adkins DR, Brown RA, Miller G, Vij R et al. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplant 2001; 27: 1059–1064.

    Article  CAS  PubMed  Google Scholar 

  • Remberger M, Aschan J, Barkholt L, Tollemar J, Ringden O . Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin. Clin Transplant 2001; 15: 147–153.

    Article  CAS  PubMed  Google Scholar 

  • McCaul KG, Nevill TJ, Barnett MJ, Toze CL, Currie CJ, Sutherland HJ et al. Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin. J Hematother Stem Cell Res 2000; 9: 367–374.

    Article  CAS  PubMed  Google Scholar 

  • Couriel D, Saliba R, Hicks K, Ippoliti C, De Lima M, Hosing C et al. Tumor necrosis factor-α blockade for the treatment of acute GVHD. Blood 2004; 104: 649–654.

    Article  CAS  PubMed  Google Scholar 

  • Marty FM, Lee SJ, Fahey MM, Alyea EP, Soiffer RJ, Antin JH et al. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood 2003; 102: 2768–2776.

    Article  CAS  PubMed  Google Scholar 

  • Wolff D, Roessler V, Steiner B, Wilhelm S, Weirich V, Brenmoehl J et al. Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplant 2005; 35: 1003–1010.

    Article  CAS  PubMed  Google Scholar 

  • Krejci M, Doubek M, Buchler T, Brychtova Y, Vorlicek J, Mayer J . Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease. Ann Hematol 2005; 84: 681–685.

    Article  CAS  PubMed  Google Scholar 

  • Bolanos-Meade J, Jacobsohn DA, Margolis J, Ogden A, Wientjes MG, Byrd JC et al. Pentostatin in steroid-refractory acute graft-versus-host disease. J Clin Oncol 2005; 23: 2661–2668.

    Article  CAS  PubMed  Google Scholar 

  • Arora M, Burns LJ, Davies SM, MacMillan ML, Defor TE, Miller WJ et al. Chronic graft-versus-host disease: a prospective cohort study. Biol Blood Marrow Transplant 2003; 9: 38–45.

    Article  PubMed  Google Scholar 

  • Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003; 102: 802–809.

    Article  CAS  PubMed  Google Scholar 

  • Lopez F, Parker P, Nademanee A, Rodriguez R, Al-Kadhimi Z, Bhatia R et al. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 307–313.

    Article  CAS  PubMed  Google Scholar 

  • Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006; 108: 756–762.

    Article  CAS  PubMed  PubMed Central  Google Scholar